NATIONAL Sarah McBride, Evan Low, HIV drug, military news, North Dakota

NATIONAL Sarah McBride, Evan Low, HIV drug, military news, North Dakota

Note: This week’s column contains graphic descriptions of a killing. Trans U.S. Rep. Sarah McBride (D-Delaware) said she will not “take a lecture on decorum from a party that incited an insurrection” a day after Republican colleague Rep. Keith Self of Texas referred to her as “Mister,” leading to an exchange that shut down a committee meeting, according to CBS Philly. After Self introduced her, McBride responded, “Thank you, Madam Chair.” Self r…

A study published by the pharmaceutical company Gilead Sciences, in the British journal The Lancet, revealed that the new drug called Lenacapavir could revolutionize the prevention and treatment of HIV. According to research, the medicine can be used annually to prevent the disease. + Read more news from Health in the West Currently, in Brazil, prevention is carried out with daily pills, administered orally. In this sense, Lenacapavir would be a…

Gilead Presents Data Demonstrating Established, Investigational HIV Drugs

Among the drugs presented, Biktarvy and lenacapavir, teropavimab, and zinlirvimab (LTZ) demonstrate rates of suppression of HIV, and vesatolimod is well tolerated.